Liquidia Corporation LQDA
Set alert
At close · Nov 2
After hours · Nov 2, 6:02 PM ET
- YTD
- +21.34%
- 1 year
- +71.80%
- Open
- 45.71
- Prev close
- 45.06
- Mkt cap
- 3.75B
- Vol
- 2.58M
- Avg vol
- 3.38M
- EPS
- 1.39
- P/E
- 30.11
- Div yield
- 0.00%
More statistics
- Low
- 41.66
- High
- 45.71
- Forward P/E
- 19.13
- Beta
- 0.41
- Short ratio
- 2.89
- Inst. own
- 81.79%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 52.99
- 200-d avg
- 54.30
- 1y target
- 54.38
5D chart
Events in this range
- Nov 2, 2026Earnings: —; estimate 0.96; surprise —%
Signals (137)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 3:25 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 3:15 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 3:15 PM | 2 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 3:00 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 3:00 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 2:50 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 2:50 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 2:35 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 2:25 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 2:20 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 2:15 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 4 hours ago |
| MACD: Buy Signal | Nov 2, 2:05 PM | 4 hours ago |
| MACD: Sell Signal | Nov 2, 1:55 PM | 4 hours ago |
| SMA: Bearish | Nov 2, 1:30 PM | 4 hours ago |
| SMA: Bullish | Nov 2, 1:15 PM | 4 hours ago |
| SMA: Bearish | Nov 2, 1:10 PM | 5 hours ago |
| SMA: Bearish | Nov 2, 1:10 PM | 5 hours ago |
| SMA: Bullish | Nov 2, 1:05 PM | 5 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 5 hours ago |
| SMA: Bearish | Nov 2, 12:05 PM | 6 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 6 hours ago |
| MACD: Buy Signal | Nov 2, 11:15 AM | 6 hours ago |
| SMA: Bearish | Nov 2, 11:10 AM | 7 hours ago |
| SMA: Bullish | Nov 2, 11:05 AM | 7 hours ago |
| RSI: Oversold | Nov 2, 10:45 AM | 7 hours ago |
| RSI: Oversold | Nov 2, 10:10 AM | 8 hours ago |
| MACD: Sell Signal | Nov 2, 10:00 AM | 8 hours ago |
| SMA: Bearish | Nov 2, 9:50 AM | 8 hours ago |
| SMA: Bearish | Nov 2, 9:50 AM | 8 hours ago |
| SMA: Bullish | Nov 2, 9:45 AM | 8 hours ago |
| SMA: Bullish | Nov 2, 9:45 AM | 8 hours ago |
| SMA: Bearish | Nov 2, 9:35 AM | 8 hours ago |
| SMA: Bullish | Nov 2, 9:30 AM | 8 hours ago |
| SMA: Bullish | Nov 2, 9:30 AM | 8 hours ago |
| SMA: Bearish | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 12:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:15 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:50 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:45 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:40 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:20 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:00 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:50 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:40 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:05 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 3:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:30 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:30 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:10 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:10 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:50 PM | 4 days ago |
| SMA: Bullish | Oct 29, 1:45 PM | 4 days ago |
| SMA: Bullish | Oct 29, 1:45 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 4 days ago |
| SMA: Bullish | Oct 29, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:20 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 12:05 PM | 4 days ago |
| RSI: Oversold | Oct 29, 11:30 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:30 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:10 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:00 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 2:00 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 1:50 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:45 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 12:15 PM | 5 days ago |
| RSI: Overbought | Oct 28, 11:40 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 11:35 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:20 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:05 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 11:05 AM | 5 days ago |
| RSI: Overbought | Oct 28, 10:05 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 9:40 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 3:10 PM | 6 days ago |
| SMA: Bullish | Oct 27, 3:10 PM | 6 days ago |
| SMA: Bearish | Oct 27, 3:05 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 2:25 PM | 6 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 6 days ago |
| RSI: Overbought | Oct 27, 1:35 PM | 6 days ago |
| MACD: Buy Signal | Oct 27, 12:50 PM | 6 days ago |
| SMA: Bullish | Oct 27, 12:45 PM | 6 days ago |
| SMA: Bullish | Oct 27, 12:45 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 12:20 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:05 PM | 6 days ago |
| SMA: Bearish | Oct 27, 11:15 AM | 6 days ago |
| SMA: Bullish | Oct 27, 11:10 AM | 6 days ago |
| SMA: Bearish | Oct 27, 11:05 AM | 6 days ago |
| SMA: Bullish | Oct 27, 10:50 AM | 6 days ago |
| SMA: Bearish | Oct 27, 10:20 AM | 6 days ago |
News
5 days ago zacks.com
Liquidia Gears Up to Report Q3 Earnings: What Can Investors Expect?
LQDA's Q3 results will spotlight the impact of its legal settlement with UTHR, cash flow pressures, profitability prospects and pipeline progress.
1 week ago zacks.com
Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?
Liquidia Corporation (LQDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
1 week ago benzinga.com
Range Resources, Xtend AI Robotics, Oruka Therapeutics And Other Big Stocks Moving Higher On Monday
U.S. stocks rose; Dow gained 350 points. Range Resources jumped 15% on EQT acquisition, while Surgery Partners and others posted sharp gains.
1 week ago newsfilecorp.com
Liquidia Corporation Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money on Your LQDA Investments
New York, New York--(Newsfile Corp. - October 21, 2026) - The law firm of Kirby McInerney LLP continues its investigation on behalf of Liquidia Corporation ("Liquidia" or the "Company") (NASDAQ:…
-
2 weeks ago benzinga.com
HC Wainwright & Co. Maintains Buy on Liquidia, Raises Price Target to $65
HC Wainwright & Co. analyst Andrew S. Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and raises the price target from $58 to $65.
2 weeks ago zacks.com
LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label
Liquidia settles six legal disputes with United Therapeutics, securing Yutrepia access for PAH patients but facing $380.7 million in payments and a narrower drug label.
2 weeks ago proactiveinvestors.com
Liquidia shares surge 25% as settlement ends United Therapeutics litigation
Liquidia Corporation (NASDAQ:LQDA), the biopharmaceutical company, surged 25% to $33.47 after settling all six pending lawsuits with United Therapeutics Corporation (NASDAQ:UTHR), ending years of…
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers MaxCyte (NASDAQ:MXCT) shares rose 34.5% to $1.3 during Wednesday's regular session. The company's market cap stands at $102.6 million. Liquidia (NASDAQ:LQDA) stock moved upwards by 26.29% to…
2 weeks ago benzinga.com
Nasdaq Dips Over 400 Points; Bank of America Shares Tumble After Q3 Results
US stocks fell Wednesday as Nasdaq dropped 1.54% and Dow 0.35%; Bank of America sank 5% after weak results, while oil rose and inflation topped forecasts.
2 weeks ago 247wallst.com
United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42%
A patent court ruling wiped out nearly half of Liquidia's stock value in a single day, and the settlement that followed cost the company almost every dollar it had in the bank.
-
2 weeks ago benzinga.com
Wells Fargo Maintains Equal-Weight on Liquidia, Raises Price Target to $33
Wells Fargo analyst Benjamin Burnett maintains Liquidia (NASDAQ:LQDA) with a Equal-Weight and raises the price target from $30 to $33.
2 weeks ago benzinga.com
Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mostly lower, with the Nasdaq Composite falling around 200 points on Wednesday.
2 weeks ago benzinga.com
Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mostly fell, but Bending Spoons surged 40% after Berkshire’s $330M investment. Liquidia and Verastem also posted strong gains.
2 weeks ago barrons.com
This Biotech Stock Surges 37% on Patent Settlement. ‘Better Than the Best-Case Scenario.
Liquidia surges after reaching a $380.7 million settlement with United Therapeutics resolving patent disputes for its lung disease drug.
2 weeks ago benzinga.com
Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain Even as September Inflation Report Comes In Hotter Than Expected— ASML, AZZ, GME in Focus (UPDATED)
U.S. stock futures were higher on Wednesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Tuesday's lower close.
2 weeks ago benzinga.com
This Albemarle Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Analysts upgraded ALB, LQDA, WY, RAL, setting or revising price targets to $130, $70, $25, $88.
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Liquidia (NASDAQ:LQDA) shares moved upwards by 41.0% to $37.8 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.4 billion. Greenland Mines…
2 weeks ago benzinga.com
Liquidia Settles Bitter Fight With United Therapeutics
Liquidia (LQDA) stock jumped 40% after settling all lawsuit battles with United Therapeutics for $380.7M. YUTREPIA PAH sales continue.
-
2 weeks ago benzinga.com
Needham Maintains Buy on Liquidia, Lowers Price Target to $58
Needham analyst Serge Belanger maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $72 to $58.
2 weeks ago benzinga.com
Why Enovix Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Enovix jumps 6.8% after securing a 100,000-unit battery order from a multinational drone maker, with deliveries planned for H1 2027.
2 weeks ago benzinga.com
Liquidia Corporation Stock Is Trending In After-Hours Following United Therapeutics Settlement: What You Should Know
Liquidia shares surged 42.48% in after-hours trading after settling all pending litigation with United Therapeutics over YUTREPIA patents.
-
2 weeks ago benzinga.com
Liquidia Will Continue To Advance YUTREPIA And L606 Clinical Programs As Previously Outlined; Liquidia Has Submitted A Supplement To Remove The PH-ILD Indication From YUTREPIA’ ’s Label And No Longer Promotes It For PH-ILD
The settlement follows the September 30, 2026, ruling by the U.S. District Court for the District of Delaware (the Court) that claims 1 and 14 of U.S. Patent No. 11,826,327 (the ’327 patent) are…
-
2 weeks ago benzinga.com
Liquidia Enters Into A Global Settlement Agreement With United Therapeutics That Resolves All Pending Litigation Between The Companies; Settlement Fully Resolves Six Ongoing Lawsuits Between Liquidia And United Therapeutics; Liquidia To Pay Net $380.70M In Installments In 2026 And 2027; Liquidia Will Make A Net Payment To UTHR Of $175M Within 30 Business Days
Liquidia Corporation (NASDAQ:LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced…
2 weeks ago globenewswire.com
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH
MORRISVILLE, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with…
3 weeks ago gurufocus.com
Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky
Liquidia Corporation (LQDA) Securities Investigation Notice - Levi and KorsinskyPR NewswireNEW YORK, Oct. 12, 2026Liquidia shareholders took a roughly 57% loss af
3 weeks ago prnewswire.com
Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky
Liquidia shareholders took a roughly 57% loss after a court found that Yutrepia infringed two valid United Therapeutics patent claims. The investigation concerns whether investors had an accurate…
3 weeks ago defenseworld.net
Liquidia (NASDAQ:LQDA) Shares Gap Up – Here’s Why
Liquidia Corporation (NASDAQ: LQDA - Get Free Report)'s stock price gapped up prior to trading on Monday. The stock had previously closed at $27.38, but opened at $29.27. Liquidia shares last traded…
3 weeks ago benzinga.com
First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday
U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C3.ai, Liquidia and others also gained.
3 weeks ago globenewswire.com
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Liquidia Corporation (LQDA)
A reported 57% plunge followed a court finding against Yutrepia. That market reaction is now the focus of a Levi & Korsinsky investigation into potential securities law violations A reported 57%…
3 weeks ago gurufocus.com
LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law
[url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv
3 weeks ago businesswire.com
LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $LQDA--LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law.
3 weeks ago globenewswire.com
LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Liquidia (LQDA) To Contact Him Directly To Discuss Their Options
3 weeks ago globenewswire.com
LIQUIDIA CORPORATION INVESTIGATION: LQDA Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Liquidia Corporation (“Liquidia” or the “Company”) (NASDAQ: LQDA). The…
3 weeks ago prnewswire.com
LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation
A court finding that Yutrepia infringed two valid claims of United Therapeutics' '327 patent has put the drug's PH-ILD indication and broader availability at risk. SueWallSt notifies investors of a…
4 weeks ago prnewswire.com
Liquidia Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Liquidia (LQDA)
LQDA shareholders who lost money after a court found that Yutrepia infringed two valid United Therapeutics patent claims may have the right to seek recovery. The investigation includes Liquidia's…
4 weeks ago defenseworld.net
Liquidia (NASDAQ:LQDA) Stock Price Down 6.1% After Analyst Downgrade
Liquidia Corporation (NASDAQ: LQDA - Get Free Report) shares dropped 6.1% on Monday after Wells Fargo and Company downgraded the stock from an overweight rating to an equal weight rating. Wells Fargo…
-
1 month ago benzinga.com
Wells Fargo Downgrades Liquidia to Equal-Weight, Lowers Price Target to $30
Wells Fargo analyst Benjamin Burnett downgrades Liquidia (NASDAQ:LQDA) from Overweight to Equal-Weight and lowers the price target from $108 to $30.
-
1 month ago benzinga.com
HC Wainwright & Co. Maintains Buy on Liquidia, Lowers Price Target to $58
HC Wainwright & Co. analyst Andrew S. Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $130 to $58.
1 month ago benzinga.com
Apple To $355? Here Are 10 Top Analyst Forecasts For Thursday
Analysts raised targets for HPE, Phillips 66, Micron and AEON; cut targets for Liquidia, Apple and Zions.
-
1 month ago benzinga.com
Raymond James Downgrades Liquidia to Outperform, Lowers Price Target to $53
Raymond James analyst Ryan Deschner downgrades Liquidia (NASDAQ:LQDA) from Strong Buy to Outperform and lowers the price target from $106 to $53.
1 month ago benzinga.com
Liquidia Stock Extends Slide Following US Court Ruling in Patent Dispute
Shares of Liquidia Corp (NASDAQ: LQDA) are sliding Thursday morning, extending a sell-off triggered by an adverse federal court patent ruling in its ongoing legal dispute with rival United…
1 month ago benzinga.com
This ExxonMobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Analysts downgraded Liquidia, Sigma Lithium, ExxonMobil, Ormat Technologies and Ethos Technologies, with updated or reduced price targets.
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) stock moved upwards by 39.4% to $4.42 during Thursday's pre-market session. The company's market cap stands at $10.1 million. Stablecoin Development (AMEX:SDEV)…
1 month ago benzinga.com
Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were mixed as Progress Software fell after results; Corteva, NFT, Vivakor and other stocks also dropped in premarket trading.
-
1 month ago benzinga.com
Needham Maintains Buy on Liquidia, Lowers Price Target to $72
Needham analyst Serge Belanger maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $110 to $72.
1 month ago benzinga.com
Why is Liquidia (LQDA) Stock Trending After Hours?
Liquidia Corp. shares gained 0.13% after hours after closing 57.19% lower following an adverse patent ruling.
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 147.1% to $0.18 during Wednesday's regular session. Tenon Medical (NASDAQ:TNON) stock increased by 47.25% to $4.02. The market value of…
1 month ago benzinga.com
Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday
U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial results; several small caps also rallied.
1 month ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
2 months ago benzinga.com
FDA Fast-Tracks Liquidia Drug for Painful Systemic Sclerosis Complication
Liquidia stock rises after the FDA grants Fast Track status to YUTREPIA for treating Raynaud’s phenomenon in systemic sclerosis.